Bidirectional association between serum carcinoembryonic antigen and metabolic syndrome among the Chinese male population: two cohort studies.
Bidirectional association
Carcinoembryonic antigen
Cohort study
Cox proportional hazards model
Hazard ratio
Metabolic syndrome
Smoking
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
04 Nov 2020
04 Nov 2020
Historique:
received:
03
08
2020
accepted:
20
10
2020
entrez:
5
11
2020
pubmed:
6
11
2020
medline:
13
8
2021
Statut:
epublish
Résumé
Previous studies have shown that serum carcinoembryonic antigen (CEA) is independently associated with metabolic syndrome (MetS). However, these studies were mainly cross-sectional analyses, and cause was not clarified. In the present study, two bidirectional cohort studies were conducted to investigate the bidirectional associations between CEA and MetS using a Chinese male sample cohort. The initial longitudinal cohort included 9629 Chinese males enrolled from January 2010 to December 2015. Two bidirectional cohorts were conducted in the study: subcohort A (from CEA to MetS, n = 6439) included participants without MetS at baseline to estimate the risk of developing incident MetS; subcohort B (from MetS to CEA, n = 8533) included participants without an elevated CEA level (Hyper-CEA) at baseline to examine the risk of developing incident Hyper-CEA. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. In subcohort A, the incidence densities of MetS among participants with and without Hyper-CEA were 84.56 and 99.28 per 1000 person-years, respectively. No significant effects of Hyper-CEA on incident MetS were observed in subcohort A (HR, 0.89; 95% CI, 0.71 to 1.12; P = 0.326). In subcohort B, a higher incidence density of Hyper-CEA was found among participants with MetS (33.42 and 29.13 per 1000 person-years for those with and without MetS, respectively). For nonsmoking participants aged > 65 years, MetS increased the risk of incident Hyper-CEA (HR, 1.87; 95% CI, 1.09 to 3.20; P = 0.022). For the direction of CEA on incident MetS, no significant association was observed. For the direction of MetS on incident Hyper-CEA, MetS in nonsmoking elderly men could increase the risk of incident Hyper-CEA, while this association was not found in other stratified participants. The clinical implications of the association between CEA and MetS should be interpreted with caution.
Identifiants
pubmed: 33148263
doi: 10.1186/s12944-020-01411-7
pii: 10.1186/s12944-020-01411-7
pmc: PMC7643476
doi:
Substances chimiques
Carcinoembryonic Antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233Subventions
Organisme : National Natural Science Foundation of China
ID : 71804093
Organisme : Shandong Provincial Medical and Health Science and Technology Development Project
ID : 2016WS0478
Organisme : Natural Science Foundation of Shandong Province
ID : ZR2015HL102
Organisme : Key Technology Research and Development Program of Shandong
ID : 2016GSF201075
Organisme : Academic Promotion Programme of Shandong First Medical University
ID : 2019LJ005
Organisme : Academic Promotion Programme of Shandong First Medical University
ID : 2019QL013
Références
Endocr Pract. 2016 Nov;22(11):1310-1318
pubmed: 27482614
Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):555-60
pubmed: 24425143
Ann Nutr Metab. 2016;68(3):173-9
pubmed: 26895247
Clin Chem Lab Med. 2013 Jul;51(7):1499-504
pubmed: 23392905
Exp Diabetes Res. 2012;2012:789174
pubmed: 22701472
JAMA. 1976 May 3;235(18):1975-9
pubmed: 56468
Toxicol Sci. 2018 Mar 1;162(1):36-42
pubmed: 29106690
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):160-5
pubmed: 17951321
Int J Clin Exp Med. 2015 Apr 15;8(4):6489-94
pubmed: 26131277
J Clin Invest. 2013 Jul;123(7):2764-72
pubmed: 23863634
Eur J Pharmacol. 2016 Aug 15;785:207-214
pubmed: 27083551
PLoS One. 2012;7(8):e43518
pubmed: 22952699
Clin Exp Metastasis. 2011 Dec;28(8):923-32
pubmed: 21901530
Clin Chim Acta. 2011 Mar 18;412(7-8):527-30
pubmed: 21138741
Nat Rev Genet. 2008 Nov;9(11):819-30
pubmed: 18852695
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Exp Gerontol. 2019 Oct 1;125:110682
pubmed: 31398443
Gastroenterol Res Pract. 2017;2017:9858931
pubmed: 28596788
Emerg Med J. 2003 Jan;20(1):54-60
pubmed: 12533370
BMC Gastroenterol. 2010 May 27;10:51
pubmed: 20507579
Int J Cancer. 2014 Jun 1;134(11):2513-22
pubmed: 23852704
Clin Chem. 2001 Apr;47(4):624-30
pubmed: 11274010
J Korean Med Sci. 2011 Jun;26(6):759-64
pubmed: 21655061
Lipids Health Dis. 2016 Apr 27;15:85
pubmed: 27121855
Diabetes Ther. 2018 Feb;9(1):209-217
pubmed: 29302932
Clin Chem Lab Med. 2010 Sep;48(9):1339-43
pubmed: 20604727